Anthropic, PBC filed a free writing prospectus on November 10, 2026, relating to its initial public offering of Class A common stock, attaching an Australian-law wrap and a Canadian-law wrap to its preliminary U.S. prospectus dated the same date.

Key Highlights

  • IPO filing: Anthropic, PBC is pursuing an initial public offering of newly issued shares of Class A Common Stock.
  • Exchange listing applied for: The company has applied to list shares on the Nasdaq Global Select Market under the symbol "ANT"; shares will not be listed on the Australian Securities Exchange.
  • Multi-jurisdiction prospectus: On November 10, 2026, Anthropic lodged an Australian prospectus (Australian-law wrap plus U.S. preliminary prospectus) and filed a Canadian second amended and restated preliminary base PREP prospectus (Canadian-law wrap plus U.S. preliminary prospectus).
  • Public benefit corporation structure: Anthropic is incorporated as a public benefit corporation under Delaware law, required to balance stockholder interests with the public benefit purpose of "the responsible development and maintenance of advanced AI for the long-term benefit of humanity."
  • Governance concentration: According to the filing, the LTBT and the Founder LLC are expected to collectively have the ability to elect all members of the board of directors, and the Founder LLC is expected to determine the outcome of all matters submitted to a stockholder vote.
  • No dividends expected: The company disclosed it does not expect to pay any dividends on its capital stock in the foreseeable future.
  • Joint book-running managers: Goldman Sachs and Co. LLC and Morgan Stanley and Co. LLC are serving as joint book-running managers, with Citigroup Global Markets Inc. as international co-ordinator and Macquarie Capital (Australia) Limited as Australian co-ordinator.

Anthropic's Cross-Border IPO Structure and Key Disclosures

The free writing prospectus, filed pursuant to Rule 433 and relating to Registration File No. 333-299633, accompanies Amendment No. 2 to Anthropic's Registration Statement on Form S-1, which was also filed on November 10, 2026. The document attaches two jurisdiction-specific wraps: an Australian Prospectus for the Australian Offer and a Canadian second amended and restated preliminary base PREP prospectus for Canadian investors. Both wraps incorporate the U.S. preliminary prospectus as a component, according to the filing.

The Australian Supplement discloses several risk factors specific to Australian investors, including that shares will trade only on NASDAQ:ANT, in a different time zone from Australia, potentially limiting investors' ability to respond to market developments in real time. The filing states that the company's financial information is reported under U.S. GAAP, which differs from the Australian Accounting Standards used by ASX-listed companies, and that holders of shares will not receive franking or similar credits even if dividends are paid. The filing also notes that investors may receive a smaller allocation than applied for, or no allocation, with any refunded amounts potentially reduced by foreign exchange conversion costs.

The filing highlights what it describes as a "novel capital and corporate governance structure." As a public benefit corporation under Delaware law, Anthropic is required to balance stockholder pecuniary interests, the interests of those materially affected by its conduct, and its stated public benefit purpose. The filing states that such requirements "may negatively impact the value of our Class A Common Stock" and "may not align with the expectations or preferences of investors." The filing further discloses that the company has "a limited operating history in an evolving and nascent industry," which it says makes it difficult to evaluate future prospects.

What Was Disclosed

Anthropic, PBC filed a free writing prospectus on November 10, 2026, attaching an Australian-law wrap and a Canadian-law wrap to its U.S. preliminary IPO prospectus, disclosing its applied-for Nasdaq listing under "ANT," its public benefit corporation structure, governance concentration, and key risks for international investors.